{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T06:31:22Z","timestamp":1793428282511,"version":"4.5.0"},"reference-count":19,"publisher":"American Association of Avian Pathologists (AAAP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Avian Diseases"],"published-print":{"date-parts":[[2023,7,6]]},"abstract":"<jats:p>Eficacia protectora de la cepa vacunal CEO Serva del virus de la laringotraque\u00edtis infecciosa (ILT) en pollos de engorde bajo diferentes condiciones de cobertura vacunal. La vacunaci\u00f3n masiva contra el virus de la laringotraque\u00edtis infecciosa (ILTV) en el agua de bebida puede resultar en una cobertura vacunal inicial variable. La cobertura vacunal inicial parcial del 20 % con una vacuna ILT australiana (A20) previamente result\u00f3 en una protecci\u00f3n significativa contra el desaf\u00edo virulento con el virus de la laringotraque\u00edtis. Este estudio de seguimiento utiliz\u00f3 la cepa de la vacuna vacunal internacional Serva ILT en un dise\u00f1o factorial para probar cuatro niveles de cobertura de vacunaci\u00f3n (0 %, 10 %, 20 % o 100 % de pollitos vacunados por gota ocular con la vacuna viva a los siete d\u00edas de edad) y tres niveles de desaf\u00edo con el virus de la laringotraque\u00edtis (sin desaf\u00edo o con desaf\u00edo a los 7 o 21 d\u00edas despu\u00e9s de la vacunaci\u00f3n [DPV]). El aumento en la carga viral en hisopos de la hendidura coanal detectados por qPCR despu\u00e9s del desaf\u00edo se redujo significativamente con cobertura de vacunaci\u00f3n del 20% y 100%, pero no con el 10%. La vacunaci\u00f3n redujo el aumento de peso en las aves no desafiadas. La ganancia diaria de peso de las aves no se vio afectada por el desaf\u00edo con el virus de la laringotraque\u00edtis a los siete d\u00edas despu\u00e9s de la vacunaci\u00f3n en ning\u00fan grupo, pero despu\u00e9s del desaf\u00edo a los 21 d\u00edas despu\u00e9s de la vacunaci\u00f3n, se redujo significativamente en los grupos no vacunados y con cobertura del 10% en comparaci\u00f3n con los grupos con cobertura del 20% y 100%. La vacunaci\u00f3n del 20 % de los pollos brind\u00f3 una protecci\u00f3n sustancial pero incompleta (con un rango de \u00edndice de protecci\u00f3n del 44 % al 70 %) contra la severidad de los signos cl\u00ednicos y la mortalidad despu\u00e9s del desaf\u00edo, mientras que la cobertura de vacunaci\u00f3n del 10 % brind\u00f3 protecci\u00f3n limitada o nula. Los signos cl\u00ednicos fueron m\u00e1s graves y aparecieron m\u00e1s temprano despu\u00e9s del desaf\u00edo a los 21 d\u00edas despu\u00e9s de la vacunaci\u00f3n en comparaci\u00f3n con el desaf\u00edo a los siete d\u00edas despu\u00e9s de la vacunaci\u00f3n. Dentro de los tratamientos de vacunaci\u00f3n, las aves vacunadas con gota ocular estaban mejor protegidas que sus cohortes en contacto. En conclusi\u00f3n, la cobertura de vacunaci\u00f3n parcial del 20%, pero no del 10% de los pollos, indujo una protecci\u00f3n sustancial contra el desaf\u00edo posterior. Sin embargo, los riesgos concomitantes de una protecci\u00f3n reducida contra el desaf\u00edo temprano y la posible reversi\u00f3n a la virulencia del virus vacunal cuando se transmite a pollos no vacunados hacen que sea esencial que la cobertura vacunal inicial del 100% sea el objetivo de los programas de vacunaci\u00f3n masiva.<\/jats:p>","DOI":"10.1637\/aviandiseases-d-22-00050","type":"journal-article","created":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T06:32:29Z","timestamp":1690353149000},"page":"160-169","source":"Crossref","is-referenced-by-count":4,"title":["Protection Efficacy of the Infectious Laryngotracheitis (ILT) Serva CEO Vaccine Strain in Broiler Chickens Under Different Vaccination Coverage Conditions"],"prefix":"10.1637","volume":"67","author":[{"given":"Awol M.","family":"Assen","sequence":"first","affiliation":[{"name":"Animal Science, School of Environmental and Rural Science, University of New England, Armidale, NSW 2351, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla F.","family":"Gerber","sequence":"additional","affiliation":[{"name":"Animal Science, School of Environmental and Rural Science, University of New England, Armidale, NSW 2351, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen W.","family":"Walkden-Brown","sequence":"additional","affiliation":[{"name":"Animal Science, School of Environmental and Rural Science, University of New England, Armidale, NSW 2351, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1212","reference":[{"key":"4","doi-asserted-by":"crossref","unstructured":"R Fulton, D Schrader, M Will,  \"Avian Dis.\"  44, \"Effect of route of vaccination on the prevention of infectious laryngotracheitis in commercial egg-laying chickens.\" 8 (2000)","DOI":"10.2307\/1592502"},{"key":"14","doi-asserted-by":"crossref","unstructured":"S Nazir, AA Yegoraw, RP Charlesworth, et al.  \"Avian Pathol.\"  49, \"Marked differences in virulence of three Australian field isolates of infectious laryngotracheitis virus in meat and layer chickens.\" 600 (2020)","DOI":"10.1080\/03079457.2020.1801987"},{"key":"5","doi-asserted-by":"crossref","unstructured":"PJ Groves, SL Williamson, SM Sharpe, et al.  \"Vaccine.\"  37, \"Uptake and spread of infectious laryngotracheitis vaccine virus within meat chicken flocks following drinking water vaccination.\" 5035 (2019)","DOI":"10.1016\/j.vaccine.2019.06.087"},{"key":"19","doi-asserted-by":"crossref","unstructured":"L. Dufour-Zavala,  \"Avian Dis.\"  52, \"Epizootiology of infectious laryngotracheitis and presentation of an industry control program.\" 1 (2008)","DOI":"10.1637\/8018-051007-Review"},{"key":"10","doi-asserted-by":"crossref","unstructured":"NC Kirkpatrick, A Mahmoudian, D O'Rourke, et al.  \"Avian Dis.\"  50, \"Differentiation of infectious laryngotracheitis virus isolates by restriction fragment length polymorphic analysis of polymerase chain reaction products amplified from multiple genes.\" 28 (2006)","DOI":"10.1637\/7414-072205R.1"},{"key":"6","doi-asserted-by":"crossref","unstructured":"JS Guy, HJ Barnes, L Smith,  \"Avian Dis.\"  35, \"Increased virulence of modified-live infectious laryngotracheitis vaccine virus following bird-to-bird passage.\" 348 (1991)","DOI":"10.2307\/1591188"},{"key":"11","doi-asserted-by":"crossref","unstructured":"MJ Coppo, JM Devlin, AH Noormohammadi,  \"Avian Pathol.\"  41, \"Comparison of the replication and transmissibility of two infectious laryngotracheitis virus chicken embryo origin vaccines delivered via drinking water.\" 195 (2012)","DOI":"10.1080\/03079457.2012.660132"},{"key":"3","doi-asserted-by":"crossref","unstructured":"M Garc\u00eda  and G Zavala  \"Avian Dis.\"  63, \"Commercial vaccines and vaccination strategies against infectious laryngotracheitis: what we have learned and knowledge gaps that remain.\" 325 (2019)","DOI":"10.1637\/11967-090218-Review.1"},{"key":"2","doi-asserted-by":"crossref","unstructured":"M. Garc\u00eda,  \"Vet Microbiol.\"  206, \"Current and future vaccines and vaccination strategies against infectious laryngotracheitis (ILT) respiratory disease of poultry.\" 157 (2017)","DOI":"10.1016\/j.vetmic.2016.12.023"},{"key":"1","doi-asserted-by":"crossref","unstructured":"M Garc\u00eda  and S Spatz  \"Diseases of poultry.\"  \"Infectious laryngotracheitis.\" 189 (2020)","DOI":"10.1002\/9781119371199.ch5"},{"key":"9","doi-asserted-by":"crossref","unstructured":"A Rodr\u00edguez-Avila, I Oldoni, S Riblet, et al.  \"Avian Pathol.\"  37, \"Evaluation of the protection elicited by direct and indirect exposure to live attenuated infectious laryngotracheitis virus vaccines against a recent challenge strain from the United States.\" 287 (2008)","DOI":"10.1080\/03079450802043742"},{"key":"7","doi-asserted-by":"crossref","unstructured":"MG Korsa, GF Browning, MJ Coppo, et al.  \"PLOS ONE.\"  10, \"Protection induced in broiler chickens following drinking-water delivery of live infectious laryngotracheitis vaccines against subsequent challenge with recombinant field virus.\" e0137719 (2015)","DOI":"10.1371\/journal.pone.0137719"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Y Samberg, E Cuperstein, U Bendheim, et al.  \"Avian Dis.\"  15, \"The development of a vaccine against avian infectious laryngotracheitis IV. Immunization of chickens with a modified laryngotracheitis vaccine in the drinking water.\" 413 (1971)","DOI":"10.2307\/1588714"},{"key":"12","doi-asserted-by":"crossref","unstructured":"AA Yegoraw, AM Assen, PF Gerber, et al.  \"Vet Res.\"  52, \"Transmission of infectious laryngotracheitis virus vaccine and field strains: the role of degree of contact and transmission by whole blood, plasma and poultry dust.\" 2021","DOI":"10.1186\/s13567-021-00959-1"},{"key":"13","doi-asserted-by":"crossref","unstructured":"AM Assen, AA Yegoraw, PF Gerber, et al.  \"Protection provided by variable vaccination coverage with A20 vaccine against infectious laryngotracheitis challenge in meat chickens.\" (2023)","DOI":"10.2139\/ssrn.4370208"},{"key":"15","doi-asserted-by":"crossref","unstructured":"NC Kirkpatrick, A Mahmoudian, CA Colson, et al.  \"Avian Pathol.\"  35, \"Relationship between mortality, clinical signs and tracheal pathology in infectious laryngotracheitis.\" 449 (2006)","DOI":"10.1080\/03079450601028803"},{"key":"16","doi-asserted-by":"crossref","unstructured":"S Callison, S Riblet, I Oldoni, et al.  \"J Viro. Methods.\"  139, \"Development and validation of a real-time Taqman\u00ae PCR assay for the detection and quantitation of infectious laryngotracheitis virus in poultry.\" 31 (2007)","DOI":"10.1016\/j.jviromet.2006.09.001"},{"key":"17","unstructured":"\"JMP, version 16.2.\"  (2022)"},{"key":"18","doi-asserted-by":"crossref","unstructured":"JM Devlin, CA Hartley, JR Gilkerson, et al.  \"Vaccine.\"  29, \"Horizontal transmission dynamics of a glycoprotein G deficient candidate vaccine strain of infectious laryngotracheitis virus and the effect of vaccination on transmission of virulent virus.\" 5699 (2011)","DOI":"10.1016\/j.vaccine.2011.06.002"}],"container-title":["Avian Diseases"],"original-title":[],"link":[{"URL":"https:\/\/bioone.org\/journals\/avian-diseases\/volume-67\/issue-2\/aviandiseases-D-22-00050\/Protection-Efficacy-of-the-Infectious-Laryngotracheitis-ILT-Serva-CEO-Vaccine\/10.1637\/aviandiseases-D-22-00050.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T05:39:35Z","timestamp":1793425175000},"score":1,"resource":{"primary":{"URL":"https:\/\/bioone.org\/journals\/avian-diseases\/volume-67\/issue-2\/aviandiseases-D-22-00050\/Protection-Efficacy-of-the-Infectious-Laryngotracheitis-ILT-Serva-CEO-Vaccine\/10.1637\/aviandiseases-D-22-00050.full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,6]]},"references-count":19,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,8,4]]}},"URL":"https:\/\/doi.org\/10.1637\/aviandiseases-d-22-00050","relation":{},"ISSN":["0005-2086","1938-4351"],"issn-type":[{"value":"0005-2086","type":"print"},{"value":"1938-4351","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,6]]}}}